A word with Andrea Taborelli – Interview with Chimica Oggi – Chemistry Today

Osteoarthritis, the most common cause of musculoskeletal disability. Let’s find out more with the IBSA NAHYCO® HYBRID TECHNOLOGY.

Osteoarthritis, the most common cause of musculoskeletal disability. Let’s find out more with the IBSA NAHYCO® HYBRID TECHNOLOGY.

As a global pharmaceutical company, IBSA is driven by a distinct vision of care, which starts at the Swiss headquarters and extends globally through continued growth in Europe, Asia, and North America. IBSA’s technologies are aimed at creating more advanced treatment systems to provide healthcare professionals with innovative, effective and reliable therapeutic solutions that improve patients’ quality of life. The product portfolioRead more